Newsfeeds - Spark Newswire

1 minute read

Precision BioSciences, Tiziana Life Ink Foralumab Deal For Cancer Indications

September 2, 9:42 AM

Precision BioSciences Inc (NASDAQ:DTIL) and Tiziana Life Sciences plc (NASDAQ:TLSA) have announced an exclusive license agreement for Tiziana’s foralumab. The companies plan to…

DTIL

5 minute read

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

By Shanthi Rexaline

September 2, 8:19 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

ABBV

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

September 2, 8:12 AM

ALKS

2 minute read

Precision BioSciences, Tiziana Life Sciences Announced Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment

By Charles Gross

September 2, 5:50 AM

Precision BioSciences, Inc.

DTIL

1 minute read

FDA
News

Tiziana Life Sciences Sponsored Study Titled ‘A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn’s Disease’ Posted To ClinicalTrials.Gov; Study Not Yet Recruiting

By Benzinga Newsdesk

August 31, 11:19 AM

https://clinicaltrials.gov/ct2/show/NCT05028946

TLSA

1 minute read

Tiziana Life Sciences ClinicalTrials.gov Listing For Co.’s ‘Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS,’ Recruitment Status Says ‘Not Yet Recruiting’

By Benzinga Newsdesk

August 31, 11:18 AM

https://clinicaltrials.gov/ct2/show/NCT05029609

TLSA

5 minute read

The Daily Biotech Pulse: Cara’s Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

By Shanthi Rexaline

August 24, 8:09 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23)

ABBV

3 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

August 23, 10:06 AM

Before 10 a.m. ET on Monday, 29 stocks hit new 52-week lows.

AGRI

11 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

August 20, 10:02 AM

On Friday morning, 155 companies achieved new lows for the year.

AAU

6 minute read

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

By Shanthi Rexaline

August 20, 7:45 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19)

ABVC